angiotensin receptor antagonist
Showing 1 - 25 of >10,000
Diabetic Kidney Disease Trial in Australia (SER150, Placebo)
Recruiting
- Diabetic Kidney Disease
- SER150
- Placebo
-
Liverpool, New South Wales, Australia
- +6 more
May 17, 2022
COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)
Recruiting
- COVID-19
- SARS-CoV2 Infection
- Candesartan Cilexetil
- +3 more
-
Guntur, India
- +4 more
Mar 13, 2022
Covid19, Angiotensin II Receptor Antagonist Adverse Reaction Trial in São Paulo (Renin-angiotensin system inhibitors)
Terminated
- Covid19
- Angiotensin II Receptor Antagonist Adverse Reaction
- Renin-angiotensin system inhibitors
-
São Paulo, SP, BrazilInstituto do Coração - Incor HCFMUSP
Sep 28, 2021
IgA Nephropathy, Proteinuria in Nephrotic Range, Immunosuppressive Treatment Trial in Beijing (Corticosteroid, Cyclophosphamide,
Recruiting
- IgA Nephropathy
- +2 more
- Corticosteroid
- +4 more
-
Beijing, ChinaPeking University First Hospital
Apr 21, 2022
Renin Angiotensin Aldosterone System Genetic Polymorphism on
Recruiting
- Myocardial Infarction
-
Cairo, EgyptAin Shams University
May 16, 2023
Coronavirus Disease(COVID)-19 Acute Respiratory Distress
Recruiting
- COVID
- Acute Respiratory Distress Syndrome
- Angiotensin II
- Interleukin-1 receptor antagonist
-
London, United KingdomGuy's & St Thomas' Hospital
Aug 3, 2021
Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists Trial in Limoges (Valsartan, Placebo Oral Tablet)
Not yet recruiting
- Aortic Valve Stenosis
- +5 more
- Valsartan
- Placebo Oral Tablet
-
Limoges, FranceLimoges university hospital
Dec 23, 2022
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li，MD
Apr 18, 2023
Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors
Not yet recruiting
- Aortic Valve Stenosis
- Angiotensin Receptor-Neprilysin Inhibitor
- antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 4, 2023
Coarctation of Aorta, High Blood Pressure Trial in Rochester (Losartan, Amlodipine, Placebo)
Not yet recruiting
- Coarctation of Aorta
- High Blood Pressure
- Losartan
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 21, 2023
Novel Antidiabetic Drug Combined With Angiotensin
Recruiting
- Type 2 Diabetes
- Antidiabetic Drugs
-
Beijing, Beijing, China
- +1 more
Jun 20, 2023
LARS - Low Anterior Resection Syndrome Trial in Seoul (Ramosetron)
Not yet recruiting
- LARS - Low Anterior Resection Syndrome
-
Seoul, Jongro-gu, Korea, Republic ofSeoul National University Hospital
Dec 13, 2022
Angiotensin Converting Enzyme Inhibitors and Angiotensin
Not yet recruiting
- COVID-19 Pneumonia
- Covid_19
- (no location specified)
Jun 5, 2022
Aortic Stenosis Trial in Québec, Odense (Angiotensin Receptor Blockers, Placebo)
Recruiting
- Aortic Stenosis
- Angiotensin Receptor Blockers
- Placebo
-
Québec, Quebec, Canada
- +1 more
Mar 28, 2022
Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)
Recruiting
- Safety Issues
- +2 more
- Proglumide
- Placebo
-
Washington, District of ColumbiaGeorgetown University
Dec 1, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Relacorilant
- +4 more
- (no location specified)
Feb 2, 2023
Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)
Completed
- Epidermolysis Bullosa
- Serlopitant Tablet
- Placebo Oral Tablet
-
Redwood City, CaliforniaStanford University
Nov 30, 2022
Monitoring Drug Efficacy in Patients With Alzheimer's Disease
Recruiting
- Alzheimer Disease
- AChE inhibitor monotherapy
- AChE inhibitor and NMDA receptor antagonist combination therapy
-
Manila, Metro Manila, PhilippinesPhilippine General Hospital
Mar 24, 2023
Surgery, Angiotensin Hypertension, Perioperative Complication Trial in Netherlands (drug, diagnostic test, behavioral)
Recruiting
- Surgery
- +2 more
- Perioperative withdrawal of angiotensin converting enzyme inhibitors and angiotenin receptor blockers
- +4 more
-
Amsterdam, Netherlands
- +6 more
Jan 6, 2022
Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)
Recruiting
- Rectal Cancer
- Kineret 100 MG in 0.67 ML Prefilled Syringe
- +3 more
-
Frankfurt, GermanyUniversity Hospital Goethe University Frankfurt
Aug 23, 2022
The Effect of RAAS Blockers on ACE2 Levels
Completed
- Renin-Angiotensin System
- ACE inhibitor ,angiotensin receptor blockers
-
Cairo, Select A State Or Province, EgyptAinshams University
Jun 10, 2022
Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic Trial in San Francisco, Salisbury (Suvorexant,
Recruiting
- Sleep Initiation and Maintenance Disorders
- Stress Disorders, Posttraumatic
- Suvorexant
- Placebo
-
San Francisco, California
- +1 more
Nov 10, 2022
Acute Kidney Injury Trial (IRBESARTAN, tablet, 150 mg, Placebo, tablet, 150 mg)
Not yet recruiting
- Acute Kidney Injury
- IRBESARTAN, tablet, 150 mg
- Placebo, tablet, 150 mg
- (no location specified)
Aug 8, 2022
Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Placebo
- Ondansetron Injection
-
Montréal, Quebec, CanadaHôpital Sacré-Coeur de Montréal
Aug 22, 2022